CDKN2A and neoplasm: Similar histological progression pattern from precancerous lesions to invasive cancer and metastasis was also observed in the p16flox/flox; LSL- KrasG12D; Pdx1-Cre mice (Fig. S3), again demonstrating that p16 inactivation promotes progression but does not alter tumor initiation and histology.